Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,275.50
-72.10 (-3.07%)
Oct 16, 2026, 3:29 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 939.77 billion as of October 16, 2026. It is the 2,139th most valuable company in the world and the 118th biggest in India. Its market cap has decreased by 6.91% in one year.
Market Cap
939.77B
Enterprise Value
983.42B
Revenue
147.38B
Global Rank
Country Rank
#118 India
PE Ratio
46.04
ChartMarket Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 939.77B, an increase of 64.94%. That is a compound annual growth rate of 15.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 939.77B | 3.64% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.43T |
| Zydus Lifesciences | 1.12T |
| Laurus Labs | 1.11T |
| Cipla | 1.07T |
| Aurobindo Pharma | 959.10B |
| Glenmark Pharmaceuticals | 628.38B |
| Alkem Laboratories | 603.80B |
| Gland Pharma | 502.06B |